Roger Adsett
Chief Operating Officer bei INSMED INCORPORATED
Vermögen: 4 Mio $ am 31.03.2024
Profil
Roger Adsett is currently an Independent Director at Landos Biopharma, Inc. since 2022.
He is also currently serving as the Chief Operating Officer at Insmed, Inc. since 2016.
Previously, he worked at AstraZeneca PLC as the Director of Marketing & Brand from 1994 to 2005.
He also held the position of Marketing Director at AstraZeneca R & D Lund and Nexium, Inc. From 2005 to 2016, he worked at Shire Plc as the SVP and Head of Gastrointestinal & Internal Medicine.
Mr. Adsett completed his undergraduate degree at Bucknell University and holds an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INSMED INCORPORATED
0,10% | 12.01.2024 | 148 559 ( 0,10% ) | 4 Mio $ | 31.03.2024 |
LANDOS BIOPHARMA, INC.
-.--% | 23.05.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Roger Adsett
| Unternehmen | Position | Beginn |
|---|---|---|
| INSMED INCORPORATED | Chief Operating Officer | 14.11.2019 |
| LANDOS BIOPHARMA, INC. | Director/Board Member | 08.03.2022 |
Ehemalige bekannte Positionen von Roger Adsett
| Unternehmen | Position | Ende |
|---|---|---|
| SHIRE | Corporate Officer/Principal | 01.09.2016 |
| ASTRAZENECA PLC | Sales & Marketing | 01.10.2005 |
| Nexium, Inc. | Sales & Marketing | - |
| AstraZeneca R & D Lund | Sales & Marketing | - |
Ausbildung von Roger Adsett
| Bucknell University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| INSMED INCORPORATED | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Nexium, Inc. | Finance |
| AstraZeneca R & D Lund |
